In order to indicate a possibility of new molecularly targeted therapy in Tau‐positive cells, further studies should confirm the cytostatic effect by the down‐regulation and overexpression of Tau proteins by using other cell lines, such as for breast cancer and neurological malignancy, with high Tau protein expression. This evidence concerns the gene MAPT and breast carcinoma.